The Scientific Advisory Board meets with the Director of the CDD once a year, and offers guidance on the Center’s long-term planning and goals.
The CDD is excited to welcome Dr. Steve Gilman of CUBIST Pharmaceuticals to its Scientific Advisory Board. Dr. Gilman was inducted at the Board meeting on December 19, 2013.
Scientific Advisory Board Members
Steven C. Gilman, Executive Vice President and Chief Scientific Officer
Andreas Goutopoulos, Director of Chemistry
Peter Isakson, Former Divisional Vice-President, Immunology Research
Abbot Bioresearch Center
George Kunos, Scientific Director of NIAAA & Senior Investigator of Neuroscience
National Institutes of Health
James Kyranos, Vice President of Chemical Technology
Anna Protopapas, President and CEO
Tomi Sawyer, Founding CSO and Senior Vice President of Drug Discovery & Innovative Technologies
Peter Schiller, Directeur, Biologie Chimique et des Polypeptides
Institut de Recherches Cliniques de Montréal
Charles Serhan, the Simon Gelman Professor of Anesthesia, Perioperative and Pain Medicine
Center for Experimental Therapeutics and Reperfusion Injury, Harvard Medical School